Researchers at the University of Kentucky are part of a groundbreaking clinical trial exploring the use of medical marijuana in managing symptoms of late-stage dementia. Greg Jicha, M.D., Ph.D., a neurologist and director of clinical trials at UK’s Sanders-Brown Center on Aging,talks with Dr. Greg about the National Institutes of Health-funded and Food and Drug Administration-approved LiBBY Study examining the potential benefits of cannabis-derived treatments for addressing agitation and discomfort in patients with advanced dementia, a population with limited palliative care options.